Reaction
Enterocolitis Haemorrhagic reporting signals
As of the last recalculation, Enterocolitis Haemorrhagic appears in 1,468 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is DASATINIB (PRR 32.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dasatinib | 81 | 32.6 | 32.7 |
| Oseltamivir Phosphate | 53 | 31.9 | 31.9 |
| Oseltamivir | 15 | 27.0 | 27.0 |
| Clarithromycin | 58 | 24.9 | 24.9 |
| Amoxicillin | 103 | 20.5 | 20.5 |
| Ipilimumab | 48 | 16.3 | 16.3 |
| Rabeprazole | 25 | 16.3 | 16.3 |
| Metronidazole Topical | 48 | 14.7 | 14.7 |
| Metronidazole | 62 | 14.3 | 14.3 |
| Imatinib | 17 | 13.8 | 13.8 |
| Ampicillin | 7 | 12.0 | 12.0 |
| Ampicillin Sodium | 7 | 12.0 | 12.0 |
| Selinexor | 6 | 9.9 | 9.9 |
| Mercaptopurine | 11 | 9.1 | 9.1 |
| Irinotecan Hydrochloride | 8 | 8.9 | 8.9 |
| Melphalan | 13 | 8.2 | 8.2 |
| Vincristine Sulfate | 15 | 7.3 | 7.3 |
| Nivolumab | 41 | 6.2 | 6.2 |
| Azacitidine | 12 | 5.8 | 5.8 |
| Azacitidine For | 7 | 5.5 | 5.5 |
| Trifluridine And Tipiracil | 4 | 5.3 | 5.3 |
| Velpatasvir And Sofosbuvir | 4 | 4.4 | 4.4 |
| Encorafenib | 3 | 4.3 | 4.3 |
| Carfilzomib | 8 | 4.0 | 4.0 |
| Ixazomib | 7 | 3.5 | 3.5 |